Reference number : 033-2012-2013-Q2-802368, amendment number : , agreement type : C, recipient legal name : Alpha Cancer Technologies Inc., recipient country : CA, recipient province : ON, recipient city : Toronto, recipient postal code : M5G1L7, program name english : Federal Economic Development Department for Ontario, program name french : Federal Economic Development Department for Ontario, program purpose english : nan, program purpose french : nan, agreement title english : 802368, agreement title french : 802368, agreement number : 802368, agreement value : 950000.0, agreement start date : 2012-04-01, agreement end date : 2014-03-31, description english : Further development and testing of a platform that uses a human protein combined with cancer drugs to target cancer cells while bypassing healthy cells., description french : sans object, expected results english : nan, expected results french : nan, additional information english : nan, additional information french : nan, owner organization : ic, owner organization title : Innovation, Science and Economic Development Canada | Innovation, Sciences et Développement économique Canada